Santhera Pharmaceuticals Holding AG (SWX: SANN)

SANN Balance Sheet

Financials in millions CHF. Fiscal year is July - June.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2023	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019
Cash & Equivalents	6.5	3.38	14.09	27.74	35.96	12.84
Cash & Short-Term Investments	6.5	3.38	14.09	27.74	35.96	12.84
Cash Growth	-53.84%	-76.01%	-49.22%	-22.85%	179.97%	-37.93%
Accounts Receivable	17.67	12.04	14.24	17.48	14.07	20.2
Other Receivables	0.46	1	2.08	1.23	0.84	1.25
Receivables	18.12	13.04	16.31	18.71	14.91	21.45
Inventory	4.09	5.11	7.4	7.98	5.38	3.58
Prepaid Expenses	4.68	4.14	4.22	3.33	3.93	2.76
Other Current Assets	-	-	-	-	-	1.82
Total Current Assets	33.4	25.66	42.02	57.76	60.18	42.45
Property, Plant & Equipment	3.04	3.21	3.89	3.51	1.77	2.35
Goodwill	-	27.48	32.55	40.78	43.91	51.03
Other Intangible Assets	38.34	12.61	12.55	5.62	1.52	2.32
Long-Term Deferred Tax Assets	5.62	5.65	5.74	6.58	5.57	5.11
Other Long-Term Assets	3.64	3.65	1.8	1.65	1.63	1.56
Total Assets	84.04	78.27	98.55	115.89	114.58	104.83
Accounts Payable	2	2.74	7.39	8.99	3.64	3.75
Accrued Expenses	20.72	10.86	12.98	14.04	12.64	10.94
Short-Term Debt	12.9	5.53	13.97	4.4	-	-
Current Portion of Long-Term Debt	-	-	-	-	-	8.44
Current Income Taxes Payable	0.52	0.53	0.42	0.28	0.34	1.48
Current Unearned Revenue	-	4.8	6.94	3.97	3.87	4.48
Other Current Liabilities	0.89	6.13	8.36	12.92	20.79	13.93
Total Current Liabilities	37.03	30.59	50.06	44.6	41.28	43.01
Long-Term Debt	24.86	23.82	24.37	24.17	24.94	0.52
Long-Term Deferred Tax Liabilities	-	0.03	0.11	0.3	0.13	0.54
Other Long-Term Liabilities	0.44	1.39	1.7	2.75	2.53	1.51
Total Liabilities	62.33	55.82	76.23	71.82	68.88	45.58
Common Stock	11.24	11.24	11.19	11.18	11.18	11.18
Retained Earnings	-38.91	-38.54	-38.56	-21.61	-14.22	-2.09
Treasury Stock	-0.15	-0	-0.81	-0.92	-1.02	-2
Comprensive Income & Other	49.31	49.53	50.29	55.26	53.24	55.1
Total Common Equity	21.49	22.24	22.11	43.91	49.18	62.2
Minority Interest	0.22	0.21	0.21	0.16	-3.48	-2.95
Shareholders' Equity	21.71	22.45	22.32	44.07	45.7	59.25
Total Liabilities & Equity	84.04	78.27	98.55	115.89	114.58	104.83
Total Debt	37.76	29.34	38.33	28.57	24.94	8.96
Net Cash (Debt)	-31.25	-25.96	-24.24	-0.83	11.02	3.89
Net Cash Growth	-	-	-	-	183.53%	-65.92%
Net Cash Per Share	-22.38	-18.64	-17.42	-0.60	7.95	2.82
Filing Date Shares Outstanding	1.4	1.4	1.39	1.39	1.39	1.38
Total Common Shares Outstanding	1.4	1.4	1.39	1.39	1.39	1.38
Working Capital	-3.63	-4.93	-8.04	13.16	18.91	-0.56
Book Value Per Share	15.32	15.83	15.91	31.58	35.44	45.01
Tangible Book Value	-16.85	-17.86	-22.99	-2.49	3.75	8.84
Tangible Book Value Per Share	-12.01	-12.71	-16.54	-1.79	2.70	6.40
Machinery	-	14.75	15.64	16.22	13.2	14.97

Source: S&P Capital IQ. Standard template. Financial Sources.